Re: Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-05-28 DOI:10.1016/j.jhep.2025.05.024

James Lok, Zillah Cargill, Mark Anderson, Gavin Cloherty, Ivana Carey

{"title":"Re: Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta","authors":"James Lok, Zillah Cargill, Mark Anderson, Gavin Cloherty, Ivana Carey","doi":"10.1016/j.jhep.2025.05.024","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors' contributions</h2><strong>Concept and design:</strong> James Lok, Ivana Carey. <strong>Data collection:</strong> James Lok, Zillah Cargill, Ivana Carey, Mark Anderson. <strong>Writing of the article:</strong> James Lok. <strong>Statistical analysis:</strong> James Lok, Ivana Carey. <strong>Critical revision of the manuscript:</strong> Mark Anderson, Gavin Cloherty, Ivana Carey. <strong>Supervision:</strong> Ivana Carey.</section></section><section><section><h2>Data availability statement</h2>Data supporting the findings of this study have been provided in the article.</section></section><section><section><h2>Financial support</h2>James Lok is funded by an MRC Clinical Research Training Fellowship (Grant number: MR/Y00168/1). In addition, the study was supported by research and development funding from Abbott Laboratories.</section></section><section><section><h2>Declaration of Competing Interest</h2>Mark Anderson and Gavin Cloherty are employees and shareholders of Abbott Laboratories. James Lok, Zillah Cargill and Ivana Carey have no conflicts of interest to declare.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"40 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.05.024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Authors' contributions

Concept and design: James Lok, Ivana Carey. Data collection: James Lok, Zillah Cargill, Ivana Carey, Mark Anderson. Writing of the article: James Lok. Statistical analysis: James Lok, Ivana Carey. Critical revision of the manuscript: Mark Anderson, Gavin Cloherty, Ivana Carey. Supervision: Ivana Carey.

Data availability statement

Data supporting the findings of this study have been provided in the article.

Financial support

James Lok is funded by an MRC Clinical Research Training Fellowship (Grant number: MR/Y00168/1). In addition, the study was supported by research and development funding from Abbott Laboratories.

Declaration of Competing Interest

Mark Anderson and Gavin Cloherty are employees and shareholders of Abbott Laboratories. James Lok, Zillah Cargill and Ivana Carey have no conflicts of interest to declare.

查看原文本刊更多论文

未治疗的慢性丁型肝炎患者的HBV RNA和HBcrAg模式差异

概念和设计：James Lok， Ivana Carey。数据收集：James Lok， Zillah Cargill, Ivana Carey, Mark Anderson。本文作者：James Lok。统计分析：James Lok， Ivana Carey。手稿的关键修订：马克·安德森，加文·克洛蒂，伊万娜·凯里。监督：伊万娜·凯里。数据可用性声明支持本研究结果的数据已在文章中提供。james Lok由MRC临床研究培训奖学金资助（资助号：MR/Y00168/1）。此外，这项研究得到了雅培实验室的研发资金支持。竞争利益声明mark Anderson和Gavin Cloherty是雅培公司的员工和股东。詹姆斯洛克，齐拉嘉吉和伊万娜凯莉没有利益冲突要申报。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.